Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$24.99
$24.99
$9.30
▼
$25.49
$1.17B1.57700,357 shsN/A
Cerus Corporation stock logo
CERS
Cerus
$2.30
+0.9%		$2.55
$1.38
▼
$3.47
$463.51M1.831.94 million shs787,964 shs
Embecta Corp. stock logo
EMBC
Embecta
$5.68
-1.2%		$5.22
$2.77
▼
$14.91
$322.11M0.841.06 million shs583,083 shs
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$13.42
+8.1%		$13.14
$9.92
▼
$35.58
$920.28M0.791.91 million shs3.58 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.00%0.00%0.00%+0.18%+118.83%
Cerus Corporation stock logo
CERS
Cerus
+0.88%+0.88%-8.37%-26.28%+36.90%
Embecta Corp. stock logo
EMBC
Embecta
-1.22%+0.53%+10.94%+75.31%-58.90%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
+8.14%+24.61%+6.17%-26.55%-51.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$24.99
$24.99
$9.30
▼
$25.49
$1.17B1.57700,357 shsN/A
Cerus Corporation stock logo
CERS
Cerus
$2.30
+0.9%		$2.55
$1.38
▼
$3.47
$463.51M1.831.94 million shs787,964 shs
Embecta Corp. stock logo
EMBC
Embecta
$5.68
-1.2%		$5.22
$2.77
▼
$14.91
$322.11M0.841.06 million shs583,083 shs
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$13.42
+8.1%		$13.14
$9.92
▼
$35.58
$920.28M0.791.91 million shs3.58 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.00%0.00%0.00%+0.18%+118.83%
Cerus Corporation stock logo
CERS
Cerus
+0.88%+0.88%-8.37%-26.28%+36.90%
Embecta Corp. stock logo
EMBC
Embecta
-1.22%+0.53%+10.94%+75.31%-58.90%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
+8.14%+24.61%+6.17%-26.55%-51.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
1.50
ReduceN/AN/A
Cerus Corporation stock logo
CERS
Cerus
2.40
Hold$5.25128.26% Upside
Embecta Corp. stock logo
EMBC
Embecta
1.60
Reduce$11.0093.66% Upside
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.50
Reduce$13.631.53% Upside

Current Analyst Ratings Breakdown

Latest EMBC, AVNS, QDEL, and CERS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2026
Embecta Corp. stock logo
EMBC
Embecta
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
9/14/2026
Cerus Corporation stock logo
CERS
Cerus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/20/2026
Cerus Corporation stock logo
CERS
Cerus
Freedom Broker
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$6.50
8/12/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/3/2026
Embecta Corp. stock logo
EMBC
Embecta
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
7/20/2026
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/17/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Embecta Corp. stock logo
EMBC
Embecta
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$715.90M1.64$3.42 per share7.30$16.73 per share1.49
Cerus Corporation stock logo
CERS
Cerus
$206.13M2.25N/AN/A$0.34 per share6.76
Embecta Corp. stock logo
EMBC
Embecta
$1.02B0.32$3.94 per share1.44($11.12) per share-0.51
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$2.67B0.34$20.33 per share0.66$28.27 per share0.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$72.90M-$1.61N/A26.59N/A-10.39%5.39%3.97%N/A
Cerus Corporation stock logo
CERS
Cerus
-$15.63M-$0.03N/AN/AN/A-3.06%-10.19%-3.14%11/5/2026 (Estimated)
Embecta Corp. stock logo
EMBC
Embecta
$95.40M$1.483.843.23N/A8.59%-19.25%10.82%11/24/2026 (Estimated)
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
-$1.13B-$15.41N/A9.13N/A-39.20%4.88%1.63%11/4/2026 (Estimated)

Latest EMBC, AVNS, QDEL, and CERS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Cerus Corporation stock logo
CERS
Cerus
-$0.0125N/AN/AN/A$63.25 millionN/A
11/4/2026Q3 2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$0.2023N/AN/AN/A$628.08 millionN/A
8/7/2026Q3 2026
Embecta Corp. stock logo
EMBC
Embecta
$0.2658$0.56+$0.2942$0.36$254.53 million$271.70 million
8/6/2026Q2 2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
-$0.0488$0.13+$0.1788-$1.36$618.72 million$630.90 million
7/30/2026Q2 2026
Cerus Corporation stock logo
CERS
Cerus
-$0.0133-$0.01+$0.0033-$0.01$62.90 million$63.30 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Cerus Corporation stock logo
CERS
Cerus
N/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
$0.040.70%N/A2.70%N/A
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A

Latest EMBC, AVNS, QDEL, and CERS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.010.8%8/27/20268/27/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.11
2.48
1.40
Cerus Corporation stock logo
CERS
Cerus
0.49
1.83
1.07
Embecta Corp. stock logo
EMBC
Embecta
N/A
1.68
1.17
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.43
1.39
0.76

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Cerus Corporation stock logo
CERS
Cerus
78.37%
Embecta Corp. stock logo
EMBC
Embecta
93.83%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
99.00%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.33%
Cerus Corporation stock logo
CERS
Cerus
5.30%
Embecta Corp. stock logo
EMBC
Embecta
1.30%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
4,04046.85 million45.76 millionOptionable
Cerus Corporation stock logo
CERS
Cerus
345201.52 million190.84 millionOptionable
Embecta Corp. stock logo
EMBC
Embecta
1,85056.66 million55.92 millionOptionable
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
6,50068.58 million67.82 millionOptionable

Recent News About These Companies

Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?
October 8 at 2:50 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-quidelortho-corporation-insiders-breach-their-fiduciary-duties-to-shareholders-302902782.html
QuidelOrtho: Margins Recover, Cash Does Not
October 7 at 12:18 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4952547-quidelortho-margins-recover-cash-does-not
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
October 7 at 7:13 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html
QuidelOrtho stock gained 12.72 percent as debt terms reset
October 7 at 1:33 AM  |  ad-hoc-news.deA
QuidelOrtho rallies 13% to multi-week high
October 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4650364-quidelortho-rallies-13-to-multi-week-high
QuidelOrtho (NASDAQ:QDEL) Shares Climb 7.2% - Time to Buy?
October 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31088018
QuidelOrtho (NASDAQ:QDEL) Shares Up 7.2% - Should You Buy?
October 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-quidelortho-nasdaq-qdel-shares-up-72-should-you-buy-2026-10-05/
Bank of America Corp DE Acquires New Stake in QuidelOrtho Corporation $QDEL
October 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-acquires-new-stake-in-quidelortho-corporation-qdel-2026-10-02/
QuidelOrtho stock trades 70.3 percent below its 52-week high
September 25, 2026  |  ad-hoc-news.deA
2 healthcare stocks with impressive fundamentals and 1 facing challenges
September 25, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/2-healthcare-stocks-with-impressive-fundamentals-and-1-facing-challenges/ar-AA2cXK6A
QuidelOrtho Corporation Enters Into Amendment No. 1 To Existing Credit Agreement
September 24, 2026  |  marketscreener.comM
QuidelOrtho (NASDAQ:QDEL) Shares Up 4.3% - Time to Buy?
September 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-quidelortho-nasdaq-qdel-shares-up-43-time-to-buy-2026-09-24/
Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
September 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/early-intervention-aids-emergency-medicine-teams-in-identifying-and-personalizing-sepsis-treatment-302888208.html
QuidelOrtho Amends Credit Agreement, Resets Covenant Levels
September 23, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/quidelortho-amends-credit-agreement-resets-covenant-levels?utm_source=marketbeat.com&utm_medium=referral
QuidelOrtho (NASDAQ:QDEL) Trading Down 6% - What's Next?
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-quidelortho-nasdaq-qdel-trading-down-6-whats-next-2026-09-18/
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Rating of "Reduce" by Analysts
September 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-quidelortho-corporation-nasdaq-qdel-given-average-rating-of-reduce-by-analysts-2026-09-17/
QDEL stock gains as QuidelOrtho beats estimates and trades near target
September 5, 2026  |  ad-hoc-news.deA
Faster Answers, Better Decisions: ADLM 2026 Highlights
August 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/faster-answers-better-decisions-adlm-2026-highlights-302861038.html
J.P. Morgan Sticks to Its Sell Rating for QuidelOrtho (QDEL)
August 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/QDEL/pressreleases/4021341/jp-morgan-sticks-to-its-sell-rating-for-quidelortho-qdel/
QuidelOrtho Earnings Call Balances Resilience And Risk
August 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/quidelortho-earnings-call-balances-resilience-and-risk?utm_source=marketbeat.com&utm_medium=referral
QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed
August 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/quidelortho-qdel-6-0-cutting-020944936.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$24.99 0.00 (0.00%)
As of 10/9/2026

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Cerus stock logo

Cerus NASDAQ:CERS

$2.30 +0.02 (+0.88%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$2.30 0.00 (-0.22%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Embecta stock logo

Embecta NASDAQ:EMBC

$5.68 -0.07 (-1.22%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$5.80 +0.12 (+2.06%)
As of 10/9/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

QuidelOrtho stock logo

QuidelOrtho NASDAQ:QDEL

$13.42 +1.01 (+8.14%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$13.30 -0.12 (-0.86%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas